384
Views
2
CrossRef citations to date
0
Altmetric
Review

Effects of curcumin, its analogues, and metabolites on various cancers: focusing on potential mechanisms

ORCID Icon, , & ORCID Icon

References

  • Hulvat, M. C. Cancer Incidence and Trends. Surg. Clin. 2020, 100(3), 469–481. DOI: 10.1016/j.suc.2020.01.002.
  • Roy, P. S.; Saikia, B. J. Cancer and Cure: A Critical Analysis. Indian J. Cancer. 2016, 53(3), 441. DOI: 10.4103/0019-509X.200658.
  • Miller, K. D.; Nogueira, L.; Mariotto, A. B.; Rowland, J. H.; Yabroff, K. R.; Alfano, C. M.; Jemal, A.; Kramer, J. L.; Siegel, R. L. Cancer Treatment and Survivorship Statistics, 2019. CA Cancer J. Clin. 2019, 69(5), 363–385. DOI: 10.3322/caac.21565.
  • Ferlay, J.; Colombet, M.; Soerjomataram, I.; Parkin, D. M.; Piñeros, M.; Znaor, A.; Bray, F. Cancer Statistics for the Year 2020: An Overview. Int. J. Cancer. 2021, 149(4), 778–789. DOI: 10.1002/ijc.33588.
  • Farhood, B.; Mortezaee, K.; Goradel, N. H.; Khanlarkhani, N.; Salehi, E.; Nashtaei, M. S.; Najafi, M.; Sahebkar, A. Curcumin as an Anti‐inflammatory Agent: Implications to Radiotherapy and Chemotherapy. J. Cell. Physiol. 2019, 234(5), 5728–5740. DOI: 10.1002/jcp.27442.
  • Nagaraju, G. P.; Aliya, S.; Zafar, S. F.; Basha, R.; Diaz, R.; El-Rayes, B. F. The Impact of Curcumin on Breast Cancer. Integr. Biol. 2012, 4(9), 996–1007. DOI: 10.1039/c2ib20088.
  • Gupta, S. C.; Patchva, S.; Aggarwal, B. B. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. Aaps J. 2013, 15(1), 195–218. DOI: 10.1208/s12248-012-9432-8.
  • Unlu, A.; Nayir, E.; Kalenderoglu, M. D.; Kirca, O.; Ozdogan, M. Curcumin (Turmeric) and Cancer. J. Balkan Union Oncol. 2016, 21(5), 1050–1060.
  • Mansouri, K.; Rasoulpoor, S.; Daneshkhah, A.; Abolfathi, S.; Salari, N.; Mohammadi, M.; Rasoulpoor, S.; Shabani, S. Clinical Effects of Curcumin in Enhancing Cancer Therapy: A Systematic Review. BMC Cancer. 2020, 20(1), 1–11. DOI: 10.1186/s12885-020-07256-8.
  • Aggarwal, B. B.; Yuan, W.; Li, S.; Gupta, S. C. Curcumin‐free Turmeric Exhibits Anti‐inflammatory and Anticancer Activities: Identification of Novel Components of Turmeric. Mol. Nutr. Food Res. 2013, 57(9), 1529–1542. DOI: 10.1002/mnfr.201200838.
  • Calibasi-Kocal, G.; Pakdemirli, A.; Bayrak, S.; Ozupek, N. M.; Sever, T.; Basbinar, Y.; Ellidokuz, H.; Yigitbasi, T. Curcumin Effects on Cell Proliferation, Angiogenesis and Metastasis in Colorectal Cancer. J. Balkan Union Oncol. 2019, 24(4), 1482–1487.
  • Kocaadam, B.; Sanlier, N. Curcumin, an Active Component of Turmeric (Curcuma Longa), and Its Effects on Health. Crit. Rev. Food Sci. Nutr. 2017, 57(13), 2889–2895. DOI: 10.1080/10408398.2015.1077195.
  • Van Nong, H.; Hung, L. X.; Thang, P. N.; Chinh, V.; Dung, P. T.; Van Trung, T.; Nga, P. T. Fabrication and Vibration Characterization of Curcumin Extracted from Turmeric (Curcuma Longa) Rhizomes of the Northern Vietnam. Springerplus. 2016, 5(1), 1–9. DOI: 10.1186/s40064-016-2812-2.
  • Rege, S.; Arya, M.; Momin, S. Mini Review on Keto-Enol Ratio of Curcuminoid. Ukr. J. Food Sci. 2019, 7(1), 27–32. DOI: 10.24263/2310-1008-2019-7-1-5.
  • Lai, Y.; Yan, Y.; Liao, S.; Li, Y.; Ye, Y.; Liu, N.; Xu, P. 3D-Quantitative Structure–activity Relationship and Antiviral Effects of Curcumin Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase. Arch. Pharmacal Res. 2020, 43(5), 489–502.
  • Dei Cas, M.; Ghidoni, R. Dietary Curcumin: Correlation Between Bioavailability and Health Potential. Nutrients. 2019, 11(9), 2147. DOI: 10.3390/nu11092147.
  • Mutlu Altundağ, E.; Yılmaz, A. M.; Koçtürk, S.; Taga, Y.; Yalçın, A. S. Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells. Nutr. Cancer. 2021, 73(4), 703–712. DOI: 10.1080/01635581.2018.1380208.
  • Selvam, C.; Prabu, S. L.; Jordan, B. C.; Purushothaman, Y.; Umamaheswari, A.; Zare, M. S. H.; Thilagavathi, R. Molecular Mechanisms of Curcumin and Its Analogs in Colon Cancer Prevention and Treatment. Life Sci. 2019, 239, 117032. DOI: 10.1016/j.lfs.2019.117032.
  • Ombredane, A. S.; Silva, V. R.; Andrade, L. R.; Pinheiro, W. O.; Simonelly, M.; Oliveira, J. V.; Pinheiro, A. C.; Gonçalves, G. F.; Felice, G. J.; Garcia, M. P. In vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review. Front. Oncol. 2021, 11. DOI: 10.3389/fonc.2021.612903.
  • Sadeghian, M.; Rahmani, S.; Jamialahmadi, T.; Johnston, T. P.; Sahebkar, A. The Effect of Oral Curcumin Supplementation on Health-Related Quality of Life: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Affective Disord. 2021, 278, 627–636. DOI: 10.1016/j.jad.2020.09.091.
  • Scaria, B.; Sood, S.; Raad, C.; Khanafer, J.; Jayachandiran, R.; Pupulin, A.; Grewal, S.; Okoko, M.; Arora, M.; Miles, L., et al. Natural Health Products (Nhp’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends. Int. J. Mol. Sci. 2020, 21(22), 8480. DOI: 10.3390/ijms21228480.
  • European Food Safety Authority. Refined Exposure Assessment for Curcumin (E 100). Efsa J. 2014, 12(10), 3876. DOI:10.2903/j.efsa.2014.3876.
  • Greil, R.; Greil-Ressler, S.; Weiss, L.; Schönlieb, C.; Magnes, T.; Radl, B.; Bolger, G. T.; Vcelar, B.; Sordillo, P. P. A Phase 1 Dose-Escalation Study on the Safety, Tolerability and Activity of Liposomal Curcumin (Lipocurc™) in Patients with Locally Advanced or Metastatic Cancer. Cancer Chemother. Pharmacol. 2018, 82(4), 695–706. DOI: 10.1007/s00280-018-3654-0.
  • Sanatani, M.; Younus, J.; Stitt, L.; Malik, N. Tolerability of the Combination of Ginger (Zingiber Officinalis), Gentian (Gentiana Lutea) and Turmeric (Curcuma Longa) in Patients with Cancer-Associated Anorexia. J. Complement. Integr. Med. 2015, 12(1), 57–60. DOI: 10.1515/jcim-2013-0064.
  • Wu, R.; Wang, L.; Yin, R.; Hudlikar, R.; Li, S.; Kuo, H. C. D.; Kong, A. N. Epigenetics/epigenomics and Prevention by Curcumin of Early Stages of Inflammatory‐driven Colon Cancer. Mol. Carcinog. 2020, 59(2), 227–236.
  • Haghi, A.; Azimi, H.; Rahimi, R. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. J. Gastrointestinal Cancer. 2017, 48(4), 314–320. DOI: 10.1007/s12029-017-9997-7.
  • Pandey, A.; Chaturvedi, M.; Mishra, S.; Kumar, P.; Somvanshi, P.; Chaturvedi, R. Reductive Metabolites of Curcumin and Their Therapeutic Effects. Heliyon. 2020, 6(11), e05469. DOI: 10.1016/j.heliyon.2020.e05469.
  • Xiang, D. B.; Zhang, K. Q.; Zeng, Y. L.; Yan, Q. Z.; Shi, Z.; Tuo, Q. H., and Liao, D. F. Curcumin: From a Controversial “Panacea” to Effective Antineoplastic Products. Medicine. 2020, 99(2), e18467.
  • Ye, M. X.; Zhao, Y. L.; Li, Y.; Miao, Q.; Li, Z. K.; Ren, X. L.; Song, L. Q.; Yin, H.; Zhang, J. Curcumin Reverses Cis-Platin Resistance and Promotes Human Lung Adenocarcinoma A549/DDP Cell Apoptosis Through HIF-1α and Caspase-3 Mechanisms. Phytomedicine. 2012, 19(8–9), 779–787.
  • Wang, X.; Zhang, Y.; Zhang, X.; Tian, W.; Feng, W., & Chen, T. The Curcumin Analogue Hydrazinocurcumin Exhibits Potent Suppressive Activity on Carcinogenicity of Breast Cancer Cells via STAT3 Inhibition. Int. J. Oncol. 2012, 40(4), 1189–1195. DOI: 10.3892/ijo.2011.1298.
  • Eskiler, G. G.; Özkan, A. D.; Kaleli, S.; Bilir, C. Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells. Int. J. Pharm. Pharm. Sci. 2019, 22, 281–291. DOI: 10.18433/jpps30493.
  • Reason, W.; Mysore, S. V.; Marilene, B. W.; Eri, S. S. Curcumin: A Review of Anti-Cancer Properties and Therapeutic Activity in Head and Neck Squamous Cell Carcinoma. Mol. Cancer. 2011, 10(12), 1–19.
  • Pignanelli, C.; Ma, D.; Noel, M.; Ropat, J.; Mansour, F.; Curran, C.; Pupulin, S.; Larocque, K.; Wu, J.; Liang, G., et al. Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs. Sci. Rep. 2017, 7(1), 1105. DOI: 10.1038/s41598-017-01230-4.
  • Vemuri, S. K.; Banala, R. R.; Subbaiah, G. P. V.; Srivastava, S. K.; Reddy, A. G.; Malarvili, T. Anti-Cancer Potential of a Mix of Natural Extracts of Turmeric, Ginger and Garlic: A Cell-Based Study. Egypt. J. Basic Appl. Sci. 2017, 4(4), 332–344. DOI: 10.1016/j.ejbas.2017.07.005.
  • Martínez, N.; Herrera, M.; Frías, L.; Provencio, M.; Pérez-Carrión, R.; Díaz, V.; Morse, M.; Crespo, M. C. A Combination of Hydroxytyrosol, Omega-3 Fatty Acids and Curcumin Improves Pain and Inflammation Among Early Stage Breast Cancer Patients Receiving Adjuvant Hormonal Therapy: Results of a Pilot Study. Clin. Transl. Oncol. 2019, 21(4), 489–498. DOI: 10.1007/s12094-018-1950-0.
  • Ryan, J. L.; Heckler, C. E.; Ling, M.; Katz, A.; Williams, J. P.; Pentland, A. P.; Morrow, G. R. Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients. Radiat. Res. 2013, 180(1), 34–43. DOI: 10.1667/RR3255.1.
  • Wright, E. L.; Frye, J. B.; Gorti, B.; Timmermann, B. N.; Funk, J. L. Bioactivity of Turmeric-Derived Curcuminoids and Related Metabolites in Breast Cancer. Curr. Pharm. Des. 2013, 19(34), 6218–6225. DOI: 10.2174/1381612811319340013.
  • Han, X.; Deng, S.; Wang, N.; Liu, Y.; Yang, X. Inhibitory Effects and Molecular Mechanisms of Tetrahydro Curcumin Against Human Breast Cancer MCF-7 Cells. Food Nutr. Res. 2016, 60(1), 30616. DOI: 10.3402/fnr.v60.30616.
  • Meiyanto, E.; Putri, H.; Larasati, Y. A.; Utomo, R. Y.; Jenie, R. I.; Ikawati, M.; Lestari, B.; Yoneda-Kato, N.; Nakamae, I.; Kawaichi, M. Anti-Proliferative and Anti-Metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation. Adv. Pharm. Bull. 2019, 9(3), 445. DOI: 10.15171/apb.2019.053.
  • Badr, G.; Gul, H. I.; Yamali, C.; Mohamed, A. A.; Badr, B. M.; Gul, M.; Markeb, A. A.; El-Maali, N. A. Curcumin Analogue 1, 5-Bis (4-Hydroxy-3-((4-Methylpiperazin-1-Yl) Methyl) Phenyl) Penta-1, 4-Dien-3-One Mediates Growth Arrest and Apoptosis by Targeting the Pi3k/akt/mtor and PKC-Theta Signaling Pathways in Human Breast Carcinoma Cells. Bioorg. Chem. 2018, 78, 46–57. DOI: 10.1016/j.bioorg.2018.03.006.
  • Al-Hujaily, E. M.; Mohamed, A. G.; Al-Sharif, I.; Youssef, K. M.; Manogaran, P. S.; Al-Otaibi, B.; Al-Haza’-A, A.; Al-Jammaz, I.; Al-Hussein, K.; Aboussekhra, A. PAC, a Novel Curcumin Analogue, Has Anti-Breast Cancer Properties with Higher Efficiency on ER-Negative Cells. Breast Cancer Res. Treat. 2011, 128(1), 97–107. DOI: 10.1007/s10549-010-1089-3.
  • Yamaguchi, M.; Zhu, S.; Zhang, S.; Wu, D.; Moore, T. M.; Snyder, J. P.; Shoji, M. Curcumin Analogue UBS109 Prevents Bone Loss in Breast Cancer Bone Metastasis Mouse Model: Involvement in Osteoblastogenesis and Osteoclastogenesis. Cell and Tissue Research. 2014, 357(1), 245–252. DOI: 10.1007/s00441-014-1846-4.
  • Barrero, M. J. Epigenetic Strategies to Boost Cancer Immunotherapies. Int. J. Mol. Sci. 2017, 18(6), 1108. DOI: 10.3390/ijms18061108.
  • Mirzaei, H.; Masoudifar, A.; Sahebkar, A.; Zare, N.; Sadri Nahand, J.; Rashidi, B.; Mehrabian, E.; Mohammadi, M.; Mirzaei, H. R.; Jaafari, M. R. MicroRna: A Novel Target of Curcumin in Cancer Therapy. J. Cell. Physiol. 2018, 233(4), 3004–3015. DOI: 10.1002/jcp.26055.
  • Zhang, T.; Zheng, P.; Shen, X.; Shao, R.; Wang, B.; Shen, H.; Zou, P. Curcuminoid WZ26, a TrxR1 Inhibitor, Effectively Inhibits Colon Cancer Cell Growth and Enhances Cisplatin-Induced Cell Death Through the Induction of ROS. Free Radical Biol. Med. 2019, 141, 93–102. DOI: 10.1016/j.freeradbiomed.2019.06.005.
  • Irving, G. R.; Iwuji, C. O.; Morgan, B.; Berry, D. P.; Steward, W. P.; Thomas, A.; Brown, K.; Howells, L. M.; et al. Combining Curcumin (C3-Complex, Sabinsa) with Standard Care FOLFOX Chemotherapy in Patients with Inoperable Colorectal Cancer (CUFOX): Study Protocol for a Randomised Control Trial. Trials. 2015, 16(1), 1–10.
  • Tong, W.; Wang, Q.; Sun, D.; Suo, J. Curcumin Suppresses Colon Cancer Cell Invasion via AMPK-Induced Inhibition of NF-κB, uPa Activator and MMP9. Oncol. Lett. 2016, 12(5), 4139–4146. DOI: 10.3892/ol.2016.5148.
  • Kasdagly, M.; Radhakrishnan, S.; Reddivari, L.; Veeramachaneni, D. R.; Vanamala, J. Colon Carcinogenesis: Influence of Western Diet-Induced Obesity and Targeting Stem Cells Using Dietary Bioactive Compounds. Nutrition. 2014, 30(11–12), 1242–1256. DOI: 10.1016/j.nut.2014.02.016.
  • He, Z. Y.; Shi, C. B.; Wen, H.; Li, F. L.; Wang, B. L.; Wang, J. Upregulation of P53 Expression in Patients with Colorectal Cancer by Administration of Curcumin. Cancer Invest. 2011, 29(3), 208–213. DOI: 10.3109/07357907.2010.550592.
  • Lin, L.; Liu, Y.; Li, H.; Li, P. K.; Fuchs, J.; Shibata, H.; Iwabuchi, Y.; Lin, J. Targeting Colon Cancer Stem Cells Using a New Curcumin Analogue, GO-Y030. Br. J. Cancer. 2011, 105(2), 212–220. DOI: 10.1038/bjc.2011.200.
  • Hejazi, J.; Rastmanesh, R.; Taleban, F. A.; Molana, S. H.; Hejazi, E.; Ehtejab, G.; Hara, N. Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study. Nutr. Cancer. 2016, 68(1), 77–85. DOI: 10.1080/01635581.2016.1115527.
  • Fu, H.; Wang, C.; Yang, D.; Wei, Z.; Xu, J.; Hu, Z.; Zhang, Y.; Wang, W.; Yan, R.; Cai, Q. Curcumin Regulates Proliferation, Autophagy, and Apoptosis in Gastric Cancer Cells by Affecting PI3K and P53 Signaling. J. Cell. Physiol. 2018, 233(6), 4634–4642. DOI: 10.1002/jcp.26190.
  • Li, W.; Zhou, Y.; Yang, J.; Li, H.; Zhang, H.; Zheng, P. Curcumin Induces Apoptotic Cell Death and Protective Autophagy in Human Gastric Cancer Cells. Oncol. Rep. 2017, 37(6), 3459–3466. DOI: 10.3892/or.2017.5637.
  • Da, W.; Zhang, J.; Zhang, R.; Zhu, J. Curcumin Inhibits the Lymphangiogenesis of Gastric Cancer Cells by Inhibiton of HMGB1/VEGF-D Signaling. Int. J. Immunopathol. Pharmacol. 2019, 33, 2058738419861600. DOI: 10.1177/2058738419861600.
  • Najafi, M.; Mortezaee, K.; Rahimifard, M.; Farhood, B.; Haghi-Aminjan, H. The Role of Curcumin/curcuminoids During Gastric Cancer Chemotherapy: A Systematic Review of Non-Clinical Study. Life Sci. 2020, 118051. DOI: 10.1016/j.lfs.2020.118051.
  • Mu, J.; Wang, X.; Dong, L.; Sun, P. Curcumin Derivative L6H4 Inhibits Proliferation and Invasion of Gastric Cancer Cell Line BGC‐823. J. Cell. Biochem. 2019, 120(1), 1011–1017. DOI: 10.1002/jcb.27542.
  • Chen, T.; Zhao, L.; Chen, S.; Zheng, B.; Chen, H.; Zeng, T.; Wang, L. The Curcumin Analogue WZ35 Affects Glycolysis Inhibition of Gastric Cancer Cells Through ROS-YAP-JNK Pathway. Food Chem. Toxicol. 2020, 137, 111131.
  • Rajamanickam, V.; Yan, T.; Wu, L.; Zhao, Y.; Xu, X.; Zhu, H.; Chen, X.; Wang, M.; Liu, Z.; Liu, Z. Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a. Cancer Manage. Res. 2020, 12, 247. DOI: 10.2147/CMAR.S227415.
  • Zhu, Y.; Bu, S. Curcumin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Pancreatic Cancer Cells. Evid. Based Complement. Altern. Med. 2017. DOI: 10.1155/2017/5787218.
  • Wang, Q.; Qu, C.; Xie, F.; Chen, L.; Liu, L.; Liang, X.; Meng, Z. Curcumin Suppresses Epithelial-To-Mesenchymal Transition and Metastasis of Pancreatic Cancer Cells by Inhibiting Cancer-Associated Fibroblasts. Am. J. Cancer Res. 2017, 7(1), 125.
  • Li, W.; Jiang, Z.; Xiao, X.; Wang, Z.; Wu, Z.; Ma, Q.; Cao, L. Curcumin Inhibits Superoxide Dismutase-Induced Epithelial-To-Mesenchymal Transition via the Pi3k/akt/nf-κB Pathway in Pancreatic Cancer Cells. Int. J. Oncol. 2018, 52(5), 1593–1602. DOI: 10.3892/ijo.2018.4295.
  • Bimonte, S.; Barbieri, A.; Leongito, M.; Piccirillo, M.; Giudice, A.; Pivonello, C.; De Angelis, C.; Granata, V.; Palaia, R.; Izzo, F. Curcumin Anticancer Studies in Pancreatic Cancer. Nutrients. 2016, 8(7), 433. DOI: 10.3390/nu8070433.
  • Bao, B.; Ali, S.; Banerjee, S.; Wang, Z.; Logna, F.; Azmi, A. S.; Kong, D.; Ahmad, A.; Li, Y.; Padhye, S. Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRnas and Attenuating EZH2 Expression. Cancer Res. 2012, 72(1), 335–345. DOI: 10.1158/0008-5472.CAN-11-2182.
  • Hutzen, B.; Friedman, L.; Sobo, M.; Lin, L.; Cen, L.; De Angelis, S.; Yamakoshi, H.; Shibata, H.; Iwabuchi, Y.; Lin, J. Curcumin Analogue GO-Y030 Inhibits STAT3 Activity and Cell Growth in Breast and Pancreatic Carcinomas. Int. J. Oncol. 2009, 35(4), 867–872. DOI: 10.3892/ijo_00000401.
  • Hosseini, M.; Hassanian, S. M.; Mohammadzadeh, E.; ShahidSales, S.; Maftouh, M.; Fayazbakhsh, H.; Khazaei, M.; Avan, A. Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives. J. Cell. Biochem. 2017, 118(7), 1634–1638. DOI: 10.1002/jcb.25897.
  • Dhillon, N.; Aggarwal, B. B.; Newman, R. A.; Wolff, R. A.; Kunnumakkara, A. B.; Abbruzzese, J. L.; Ng, C. S.; Badmaev, V.; Kurzrock, R. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer. Clin. Cancer Res. 2008, 14(14), 4491–4499.
  • Cao, L.; Liu, J.; Zhang, L.; Xiao, X.; Li, W. Curcumin Inhibits H2O2-Induced Invasion and Migration of Human Pancreatic Cancer via Suppression of the ERK/NF-κB Pathway. Oncol. Rep. 2016, 36(4), 2245–2251. DOI: 10.3892/or.2016.5044.
  • Nonn, L.; Duong, D.; Peehl, D. M. Chemopreventive Anti-Inflammatory Activities of Curcumin and Other Phytochemicals Mediated by MAP Kinase Phosphatase-5 in Prostate Cells. Carcinogenesis. 2007, 28(6), 1188–1196. DOI: 10.1093/carcin/bgl241.
  • Lee, H. H.; Cho, H. Improved Anti-Cancer Effect of Curcumin on Breast Cancer Cells by Increasing the Activity of Natural Killer Cells. J. Microbiol. Biotechnol. 2018, 28(6), 874–882. DOI: 10.4014/jmb.1801.01074.
  • Liu, Q.; Loo, W. T.; Sze, S. C. W.; Tong, Y. Curcumin Inhibits Cell Proliferation of MDA-MB-231 and BT-483 Breast Cancer Cells Mediated by Down-Regulation of NFκB, cyclinD and MMP-1 Transcription. Phytomedicine. 2009, 16(10), 916–922. DOI: 10.1016/j.phymed.2009.04.008.
  • Li, X.; Xie, W.; Xie, C.; Huang, C.; Zhu, J.; Liang, Z.; Zhong, C. Curcumin Modulates miR‐19/pten/akt/p53 Axis to Suppress Bisphenol A‐induced MCF‐7 Breast Cancer Cell Proliferation. Phytotherapy Res. 2014, 28(10), 1553–1560.
  • Ren, B.; Luo, S.; Tian, X.; Jiang, Z.; Zou, G.; Xu, F.; Yin, T.; Huang, Y.; Liu, J. Curcumin Inhibits Liver Cancer by Inhibiting DAMP Molecule HSP70 and TLR4 Signaling. Oncol. Rep. 2018, 40(2), 895–901. DOI: 10.3892/or.2018.6485.
  • Silva, G.; Teixeira Lima, F.; Seba, V.; Mendes Lourenco, A. L.; Lucas, T. G.; De Andrade, B. V.; Marins, M. Curcumin Analog CH-5 Suppresses the Proliferation, Migration, and Invasion of the Human Gastric Cancer Cell Line HGC-27. Molecules. 2018, 23(2), 279.
  • Piantino, C. B.; Salvadori, F. A.; Ayres, P. P.; Kato, R. B.; Srougi, V.; Leite, K. R.; Srougi, M. An Evaluation of the Anti-Neoplastic Activity of Curcumin in Prostate Cancer Cell Lines. Int. Braz. J. Urol. 2009, 35(3), 354–361. DOI: 10.1590/S1677-55382009000300012.
  • Ma, D.; Tremblay, P.; Mahngar, K.; Collins, J.; Hudlicky, T.; Pandey, S. Selective Cytotoxicity Against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin is Potentiated by Curcumin. PLoS One. 2011, 6(12), e28780. DOI: 10.1371/journal.pone.0028780.
  • Zhao, Z.; Li, C.; Xi, H.; Gao, Y.; Xu, D. Curcumin Induces Apoptosis in Pancreatic Cancer Cells Through the Induction of Forkhead Box O1 and Inhibition of the Pi3k/akt Pathway. Mol. Med. Rep. 2015, 12(4), 5415–5422. DOI: 10.3892/mmr.2015.4060.
  • Osterman, C. J. D.; Gonda, A.; Stiff, T.; Sigaran, U.; Valenzuela, M. M. A.; Bennit, H. R. F.; Moyron, R. B.; Khan, S.; Wall, N. R. Curcumin Induces Pancreatic Adenocarcinoma Cell Death via Reduction of the Inhibitors of Apoptosis. Pancreas. 2016, 45(1), 101. DOI: 10.1097/MPA.0000000000000411.
  • Zhang, Y.; Kong, Y.; Liu, S.; Zeng, L.; Wan, L.; Zhang, Z. Curcumin Induces Apoptosis in Human Leukemic Cell Lines Through an IFIT2-Dependent Pathway. Cancer Biol. Ther. 2017, 18(1), 43–50. DOI: 10.1080/15384047.2016.1276129.
  • Parashar, K.; Sood, S.; Mehaidli, A.; Curran, C.; Vegh, C.; Nguyen, C.; Pignanelli, C.; Wu, J.; Liang, G.; Wang, Y., et al. Evaluating the Anti-Cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics. Molecules. 2019, 24(13), 2483. DOI: 10.3390/molecules24132483.
  • Zhou, H.; Ning, Y.; Zeng, G.; Zhou, C.; Ding, X. Curcumin Promotes Cell Cycle Arrest and Apoptosis of Acute Myeloid Leukemia Cells by Inactivating AKT. Oncol. Rep. 2021, 45(4), 1. DOI: 10.3892/or.2021.7962.
  • Su, J.; Zhou, X.; Yin, X.; Wang, L.; Zhao, Z.; Hou, Y.; Zheng, N.; Xia, J.; Wang, Z. The Effects of Curcumin on Proliferation, Apoptosis, Invasion, and NEDD4 Expression in Pancreatic Cancer. Biochem. Pharmacol. 2017, 140, 28–40. DOI: 10.1016/j.bcp.2017.05.014.
  • Liu, L. D.; Pang, Y. X.; Zhao, X. R.; Li, R.; Jin, C. J.; Xue, J.; Dong, R. Y.; Liu, P. S. Curcumin Induces Apoptotic Cell Death and Protective Autophagy by Inhibiting Akt/mtor/p70s6k Pathway in Human Ovarian Cancer Cells. Arch. Gynecol. Obstet. 2019, 299(6), 1627–1639. DOI: 10.1007/s00404-019-05058-3.
  • Wang, T.; Wu, X. Curcumin Induces G2/M Arrest and Triggers Autophagy, ROS Generation and Cell Senescence in Cervical Cancer Cells. J. Cancer. 2020, 11(22), 6704. DOI: 10.7150/jca.45176.
  • Xie, C.; Zhu, J.; Yang, X.; Huang, C.; Zhou, L.; Meng, Z.; Zhong, C. TAp63α is Involved in Tobacco Smoke-Induced Lung Cancer EMT and the Anti-Cancer Activity of Curcumin via miR-19 Transcriptional Suppression. Front. Cell Dev. Biol. 2021, 9, 465. DOI: 10.3389/fcell.2021.645402.
  • Darvesh, A. S.; Aggarwal, B. B.; Bishayee, A. Curcumin and Liver Cancer: A Review. Curr. Pharm. Biotechnol. 2012, 13(1), 218–228. DOI: 10.2174/138920112798868791.
  • Wang, J.; Wang, C.; Bu, G. Curcumin Inhibits the Growth of Liver Cancer Stem Cells Through the Phosphatidylinositol 3-Kinase/protein Kinase B/mammalian Target of Rapamycin Signaling Pathway. Exp. Ther. Med. 2018a, 15(4), 3650–3658. DOI: 10.3892/etm.2018.5805.
  • Gu, X.; Zhang, Q.; Zhang, W.; Zhu, L. Curcumin Inhibits Liver Metastasis of Gastric Cancer Through Reducing Circulating Tumor Cells. Aging (Albany NY). 2019, 11(5), 1501. DOI: 10.18632/aging.101848.
  • Deng, Z.; Xu, X. Y.; Yunita, F.; Zhou, Q.; Wu, Y. R.; Hu, Y. X.; Wang, Z. Q.; Tian, X. F. Synergistic Anti-Liver Cancer Effects of Curcumin and Total Ginsenosides. World J. Gastrointestinal Oncol. 2020, 12(10), 1091. DOI: 10.4251/wjgo.v12.i10.1091.
  • Wang, J. Y.; Wang, X.; Wang, X. J.; Zheng, B. Z.; Wang, Y.; Wang, X.; Liang, B. Curcumin Inhibits the Growth via Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer Cells. Eur. Rev. Med. Pharmacol. Sci. 2018b, 22(21), 7492–7499. DOI: 10.26355/eurrev_201811_16290.
  • Guo, Y.; Li, Y.; Shan, Q.; He, G.; Lin, J.; Gong, Y. Curcumin Potentiates the Anti-Leukemia Effects of Imatinib by Downregulation of the Akt/mtor Pathway and BCR/ABL Gene Expression in Ph+ Acute Lymphoblastic Leukemia. Int. J. Biochem. Cell Biol. 2015, 65, 1–11. DOI: 10.1016/j.biocel.2015.05.003.
  • Martínez-Castillo, M.; Villegas-Sepúlveda, N.; Meraz-Rios, M. A.; Hernández-Zavala, A.; Berumen, J.; Coleman, M. A.; Orozco, L.; Cordova, E. J. Curcumin Differentially Affects Cell Cycle and Cell Death in Acute and Chronic Myeloid Leukemia Cells. Oncol. Lett. 2018, 15(5), 6777–6783. DOI: 10.3892/ol.2018.8112.
  • Ulusoy, H. G.; Sanlier, N. A Minireview of Quercetin: From Its Metabolism to Possible Mechanisms of Its Biological Activities. Crit. Rev. Food Sci. Nutr. 2020, 60(19), 3290–3303. DOI: 10.1080/10408398.2019.1683810.
  • Hsiao, P. C.; Chang, J. H.; Lee, W. J.; Ku, C. C.; Tsai, M. Y.; Yang, S. F.; Chien, M. H. The Curcumin Analogue, EF-24, Triggers P38 MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK Deactivation in Human Acute Myeloid Leukemia Cells. Cancers. 2020, 12(8), 2163. DOI: 10.3390/cancers12082163.
  • Weng, Q.; Ren, L.; Guo, L.; Hu, Y.; Zhou, H.; Bao, Y.; Chen, L.; Liang, G.; Wang, Y.; Ruan, J. Curcumin Analogue, A13, Exhibits Anti-Leukemia Effect via Inhibiting STAT3. Tumor Biol. 2016, 37(7), 9959–9966.
  • Sundram, V.; Chauhan, S. C.; Ebeling, M.; Jaggi, M. Curcumin Attenuates β-Catenin Signaling in Prostate Cancer Cells Through Activation of Protein Kinase D1. PLoS One. 2012, 7(4), e35368. DOI: 10.1371/journal.pone.0035368.
  • Javed, Z.; Khan, K.; Rasheed, A.; Sadia, H.; Shahwani, M. N.; Irshad, A.; Raza, S.; Salehi, B.; Sharifi-Rad, J.; Suleria, H. A. R. Targeting Androgen Receptor Signaling with MicroRnas and Curcumin: A Promising Therapeutic Approach for Prostate Cancer Prevention and Intervention. Cancer Cell Int. 2021, 21(1), 1–13. DOI: 10.1186/s12935-021-01777-3.
  • Lin, L.; Shi, Q.; Nyarko, A. K.; Bastow, K. F.; Wu, C. C.; Su, C. Y.; Y-Shih, C. C.; Lee, K. H. Antitumor Agents. 250. Design and Synthesis of New Curcumin Analogues as Potential Anti-Prostate Cancer Agents. J. Med. Chem. 2006, 49(13), 3963–3972. DOI: 10.1021/jm051043z.
  • Luo, C.; Li, Y.; Zhou, B.; Yang, L.; Li, H.; Feng, Z.; Li, Y.; Long, J.; Liu, J. A Monocarbonyl Analogue of Curcumin, 1, 5-Bis (3-Hydroxyphenyl)-1, 4-Pentadiene-3-One (Ca 37), Exhibits Potent Growth Suppressive Activity and Enhances the Inhibitory Effect of Curcumin on Human Prostate Cancer Cells. Apoptosis. 2014, 19(3), 542–553. DOI: 10.1007/s10495-013-0947-y.
  • Hejazi, J.; Rastmanesh, R.; Taleban, F. A.; Molana, S. H.; Ehtejab, G. A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer. J. Cancer Sci. Ther. 2013, 5, 320–324.
  • Kim, B.; Kim, H. S.; Jung, E. J.; Lee, J. Y.; Tsang, B. K.; Lim, J. M.; Song, Y. S. Curcumin Induces ER Stress‐mediated Apoptosis Through Selective Generation of Reactive Oxygen Species in Cervical Cancer Cells. Mol. Carcinog. 2016, 55(5), 918–928. DOI: 10.1002/mc.22332.
  • Ghasemi, F.; Shafiee, M.; Banikazemi, Z.; Pourhanifeh, M. H.; Khanbabaei, H.; Shamshirian, A.; Mirzaei, H. Curcumin Inhibits NF-kB and Wnt/β-Catenin Pathways in Cervical Cancer Cells. Pathol. Res. Pract. 2019, 215(10), 152556. DOI: 10.1016/j.prp.2019.152556.
  • Aedo Aguilera, V.; Carrillo Beltrán, D. G.; Calaf, M.; Muñoz, J. P.; Guerrero, N.; Osorio, J. C.; Tapia, J. C.; Léon, O.; Contreras, H. R.; Aguayo, F. Curcumin Decreases Epithelial Mesenchymal Transition by a Pirin Dependent Mechanism in Cervical Cancer Cells. Oncol. Rep. 2019, 42(5), 2139–2148. DOI: 10.3892/or.2019.7288.
  • Shang, H. S.; Chang, C. H.; Chou, Y. R.; Yeh, M. Y.; Au, M. K.; Lu, H. F.; Chung, J. G. Curcumin Causes DNA Damage and Affects Associated Protein Expression in HeLa Human Cervical Cancer Cells. Oncol. Rep. 2016, 36(4), 2207–2215.
  • Paulraj, F.; Abas, F.; Lajis, N. H.; Othman, I.; Hassan, S. S.; Naidu, R. The Curcumin Analogue 1, 5-Bis (2-Hydroxyphenyl)-1, 4-Pentadiene-3-One Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells. Molecules. 2015, 20(7), 11830–11860. DOI: 10.3390/molecules200711830.
  • Choe, S. R.; Kim, Y. N.; Park, C. G.; Cho, K. H.; Lee, H. Y. RCP Induces FAK Phosphorylation and Ovarian Cancer Cell Invasion with Inhibition by Curcumin. Exp. Mol. Med. 2018, 50(4), 1–10. DOI: 10.1038/s12276-018-0078-1.
  • Qu, W.; Xiao, J.; Zhang, H.; Chen, Q.; Wang, Z.; Shi, H.; Gong, L.; Chen, J.; Liu, Y.; Cao, R. B19, a Novel Monocarbonyl Analogue of Curcumin, Induces Human Ovarian Cancer Cell Apoptosis via Activation of Endoplasmic Reticulum Stress and the Autophagy Signaling Pathway. Int. J. Bio. Sci. 2013, 9(8), 766. DOI: 10.7150/ijbs.5711.
  • Zhang, X.; Zhang, H. Q.; Zhu, G. H.; Wang, Y. H.; Yu, X. C.; Zhu, X. B.; Li, X. K. A Novel Mono-Carbonyl Analogue of Curcumin Induces Apoptosis in Ovarian Carcinoma Cells via Endoplasmic Reticulum Stress and Reactive Oxygen Species Production. Mol. Med. Rep. 2012, 5(3), 739–744. DOI: 10.3892/mmr.2011.700.
  • Sirotkin, A. V.; Harrath, A. H. Phytoestrogens and Their Effects. Eur. J. Pharmacol. 2014, 741, 230–236.
  • Valentine, S. P.; Le Nedelec, M. J.; Menzies, A. R.; Scandlyn, M. J.; Goodin, M. G.; Rosengren, R. J. Curcumin Modulates Drug Metabolizing Enzymes in the Female Swiss Webster Mouse. Life Sci. 2006, 78, 2391–2398.
  • Fatemi Abhari, S. M.; Khanbabaei, R.; Hayati Roodbari, N.; Parivar, K.; Yaghmaei, P. Curcumin-Loaded Super-Paramagnetic Iron Oxide Nanoparticle Affects on Apoptotic Factors Expression and Histological Changes in a Prepubertal Mouse Model of Polycystic Ovary Syndrome-Induced by Dehydroepiandrosterone – a Molecular and Stereological Study. Life Sci. 2020, 249, 117515.
  • Kádasi, A.; Maruniaková, N.; Štochmaľová, A.; Bauer, M.; Grossmann, R.; Harrath, A. H.; Kolesárová, A.; Sirotkin, A. V. Direct Effect of Curcumin on Porcine Ovarian Cell Functions. Anim. Reprod. Sci. 2017, 182, 77–83.
  • Carr, K. R.; Ioffe, Y. J.; Filippova, M.; Duerksen-Hughes, P.; Chan, P. J. Combined Ultrasound-Curcumin Treatment of Human Cervical Cancer Cells. Eur. J. Obstet. Gynecol. Reprod. Bio. 2015, 193, 96–101.
  • Yoysungnoen-Chintana, P.; Bhattarakosol, P.; Patumraj, S. Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice. Biomed. Res. Int. 2014, 817972.
  • Sirohi, V. K.; Popli, P.; Sankhwar, P.; Kaushal, J. B.; Gupta, K.; Manohar, M.; Dwivedi, A. Curcumin Exhibits Anti-Tumor Effect and Attenuates Cellular Migration via Slit-2 Mediated Down-Regulation of SDF-1 and CXCR4 in Endometrial Adenocarcinoma Cells. J. Nutr. Biochem. 2017, 44, 60–70.
  • Yoysungnoen, B.; Bhattarakosol, P.; Changtam, C., and Patumraj, S. Effects of Tetrahydrocurcumin on Tumor Growth and Cellular Signaling in Cervical Cancer Xenografts in Nude Mice. Biomed Res. Int. 2016, 1781208, 1–11.
  • Mehta, H. J.; Patel, V.; Sadikot, R. T. Curcumin and Lung Cancer—a Review. Targeted Oncol. 2014, 9(4), 295–310. DOI: 10.1007/s11523-014-0321-1.
  • Wan Mohd Tajuddin, W. N. B.; Lajis, N. H.; Abas, F.; Othman, I.; Naidu, R. Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer. Nutrients. 2019, 11(12), 2989. DOI: 10.3390/nu11122989.
  • Wang, L.; Han, L.; Tao, Z.; Zhu, Z.; Han, L.; Yang, Z.; Wang, H.; Dai, D.; Wu, L.; Yuan, Z. The Curcumin Derivative WZ35 Activates ROS-Dependent JNK to Suppress Hepatocellular Carcinoma Metastasis. Food Funct. 2018, 9(5), 2970–2978. DOI: 10.1039/C8FO00314A.
  • Lelli, D.; Pedone, C.; Majeed, M.; Sahebkar, A. Curcumin and Lung Cancer: The Role of microRnas. Curr. Pharm. Des. 2017, 23(23), 3440–3444. DOI: 10.2174/1381612823666170109144818.
  • Ichiki, K.; Mitani, N.; Doki, Y.; Hara, H.; Misaki, T.; Saiki, I. Regulation of Activator Protein-1 Activity in the Mediastinal Lymph Node Metastasis of Lung Cancer. Clin. Exp. Metastasis. 2000, 18(7), 539–545. DOI: 10.1023/A:1011980313237.
  • Ashrafizadeh, M.; Najafi, M.; Makvandi, P.; Zarrabi, A.; Farkhondeh, T.; Samarghandian, S. Versatile Role of Curcumin and Its Derivatives in Lung Cancer Therapy. J. Cell. Physiol. 2020, 235(12), 9241–9268. DOI: 10.1002/jcp.29819.
  • Xia, Y. Q.; Wei, X. Y.; Li, W. L.; Kanchana, K.; Xu, C. C.; Chen, D. H.; Liang, G. Curcumin Analogue A501 Induces G2/M Arrest and Apoptosis in Non-Small Cell Lung Cancer Cells. Asian Pac. J. Cancer Prev. 2014, 15(16), 6893–6898.
  • Liu, H.; Zhou, B. H.; Qiu, X.; Wang, H. S.; Zhang, F.; Fang, R.; Wang, X. F.; Cai, S. H.; Du, J.; Bu, X. Z. T63, a New 4-Arylidene Curcumin Analogue, Induces Cell Cycle Arrest and Apoptosis Through Activation of the Reactive Oxygen Species–foxo3a Pathway in Lung Cancer Cells. Free Radical Biol. Med. 2012, 53(12), 2204–2217. DOI: 10.1016/j.freeradbiomed.2012.10.537.
  • Zhou, G. Z.; Xu, S. L.; Sun, G. C.; Chen, X. B. Novel Curcumin Analogue IHCH Exhibits Potent Anti Proliferative Effects by Inducing Autophagy in A549 Lung Cancer Cells. Mol. Med. Rep. 2014, 10(1), 441–446. DOI: 10.3892/mmr.2014.2183.
  • Chen, J.; Wang, F. L.; Chen, W. D. Modulation of Apoptosis-Related Cell Signalling Pathways by Curcumin as a Strategy to Inhibit Tumor Progression. Mol. Biol. Rep. 2014, 41(7), 4583–4594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.